Thermo Fisher Scientific Inc.
TMO- Exchange
- NYSE
- Industry
- Measuring & Controlling Devices, NEC
- SEC CIK
- 0000097745
In the last 90 days, Thermo Fisher Scientific Inc. insiders filed 0 open-market purchases and 11 sales; 2,628 institutions reported holding it in 13F filings for Q2 2026, worth $169.2B in total; 6 superinvestors hold it, including Viking Global Investors and D1 Capital Partners.
13F holders, Q4 2025
Institutional positions in Thermo Fisher Scientific Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2,708
- +253 vs. Q3 2025
- Shares held
- 375.0M
- +44.2M (+13.4%) vs. Q3 2025
- Total value
- $199.1B
- +$38.9B (+24.3%) vs. Q3 2025
- New holders
- 373
- 945 more added
- Sold out
- 120
- 1,041 more reduced
60 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TMO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2,628 | $169.2B |
| Q1 2026 | 2,612 | $164.1B |
| Q4 2025 | 2,708 | $199.1B |
| Q3 2025 | 2,515 | $160.7B |
| Q2 2025 | 2,460 | $135.6B |
| Q1 2025 | 2,577 | $167.8B |
| Q4 2024 | 2,625 | $176.4B |
| Q3 2024 | 2,580 | $208.3B |
| Q2 2024 | 2,554 | $187.5B |
| Q1 2024 | 2,535 | $196.3B |
| Q4 2023 | 2,496 | $181.6B |
| Q3 2023 | 2,370 | $173.1B |
| Q2 2023 | 2,392 | $177.8B |
| Q1 2023 | 2,391 | $196.1B |
| Q4 2022 | 2,379 | $190.1B |
| Q3 2022 | 2,270 | $175.3B |
| Q2 2022 | 2,287 | $186.4B |
| Q1 2022 | 2,321 | $203.3B |
| Q4 2021 | 2,347 | $230.1B |
| Q3 2021 | 2,135 | $197.5B |
| Q2 2021 | 2,082 | $172.9B |
| Q1 2021 | 2,046 | $157.2B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Thermo Fisher Scientific Inc.; share changes are against Q3 2025.